Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients
Kathelijn Fischer, Ronan Pendu, Carina J. van Schooten et al. · 2009
Read Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients by Kathelijn Fischer, Ronan Pendu, Carina J. van Schooten et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006745.txt.
Description
Kathelijn Fischer and colleagues built models to predict treatment dosing in severe haemophilia in PLOS ONE in 2009. Factor VIII is the clotting protein these patients lack. How long a dose lasts depends heavily on von Willebrand factor. That partner protein protects factor VIII in the blood. Its level before infusion tracks with factor VIII half-life.
The team used standardized half-life studies to build prediction models. Blood group turned out to change the picture. Separate models were needed for group O and non-O patients. Predicting half-life in advance helps doctors tailor doses to each patient. Better tailoring can prevent bleeds while avoiding wasted concentrate.
Catalog record
| CREATOR | Kathelijn Fischer, Ronan Pendu, Carina J. van Schooten et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006745